Connect with us

Technology

Verra Mobility Schedules Second Quarter 2024 Earnings Call

Published

on

MESA, Ariz., July 16, 2024 /PRNewswire/ — Verra Mobility Corporation (NASDAQ: VRRM), a leading provider of smart mobility technology solutions, announced today that it will report financial results for the second quarter ended June 30, 2024, after market close on August 8, 2024.

Verra Mobility’s Chief Executive Officer, David Roberts, and Chief Financial Officer, Craig Conti, will host a conference call and live webcast to discuss financial results for investors and analysts at 5:00 p.m. ET on August 8, 2024.

To access the conference call, dial 1-800-717-1738 (U.S. toll-free) or 1-646-307-1865 (International) or click on the following link and request a return call: callme.viavid.com. A live webcast will be available on the Company’s Investor Relations website at ir.verramobility.com.

An audio replay of the call will also be available until 11:59 p.m. ET on August 22, 2024, by dialing 1-844-512-2921 (U.S. toll-free), or 1-412-317-6671 (International) and entering passcode 1122452.

In addition, an archived webcast will be available in the “News & Events” section of Verra Mobility’s Investor Relations website at ir.verramobility.com.

About Verra Mobility

Verra Mobility Corporation (NASDAQ: VRRM) is a leading provider of smart mobility technology solutions that make transportation safer, smarter and more connected. The company sits at the center of the mobility ecosystem, bringing together vehicles, hardware, software, data and people to enable safe, efficient solutions for customers globally. Verra Mobility’s transportation safety systems and parking management solutions protect lives, improve urban and motorway mobility and support healthier communities. The company also solves complex payment, utilization and compliance challenges for fleet owners and rental car companies. Headquartered in Arizona, Verra Mobility operates in North America, Europe, Asia and Australia. For more information, please visit www.verramobility.com.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about Verra Mobility’s plans, objectives, expectations, beliefs and intentions and other statements including words such as “hope,” “anticipate,” “may,” “believe,” “expect,” “intend,” “will,” “should,” “plan,” “estimate,” “predict,” “continue” and “potential” or the negative of these terms or other comparable terminology. The forward-looking statements herein represent the judgment of the Verra Mobility, as of the date of this release, and Verra Mobility disclaims any intent or obligation to update forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those currently anticipated. This press release should be read in conjunction with the information included in Verra Mobility’s other press releases, reports and other filings with the SEC and on the SEC website, www.sec.gov. Understanding the information contained in these filings is important in order to fully understand Verra Mobility’s reported financial results and our business outlook for future periods. Actual results may differ materially from the results anticipated in the forward-looking statements and the assumptions and estimates used as a basis for the forward-looking statements.

Additional Information

We periodically provide information for investors on our corporate website, www.verramobility.com, and our investor relations website, ir.verramobility.com. We intend to use our website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our website, in addition to following the Company’s press releases, SEC filings and public conference calls and webcasts.

Media Relations:

Investor Relations:

Eric Krantz

Mark Zindler

eric.krantz@verramobility.com

mark.zindler@verramobility.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/verra-mobility-schedules-second-quarter-2024-earnings-call-302198218.html

SOURCE Verra Mobility

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

NIIMBL Announces 11 New Technology, Workforce, and Global Health Fund Projects

Published

on

By

NEWARK, Del., April 29, 2025 /PRNewswire/ — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 11 new member-led technology, workforce development, and Global Health Fund projects with a value of ~$11.2 million through the Institute’s Project Call 8.1. This new slate of collaborative projects addresses key industry challenges and aims to strengthen domestic biopharmaceutical manufacturing capabilities.

Six projects focus on priority technology areas identified by NIIMBL industry members, including manufacturing platforms for biopharmaceutical products, process analytical technologies, and data science and modeling.

“NIIMBL members are well-positioned to advance current state-of-the-art processes and analytical technologies,” said Sandeep Kedia, NIIMBL Senior Technology Fellow. “We are excited about the potential these projects have to advance our ability to manufacture biologic products and push the boundaries of what is possible in biomanufacturing.”

The slate of new projects also includes three workforce projects aimed at building awareness and talent pipeline development, ensuring the U.S. has the strongest biopharmaceutical workforce globally.

“To meet the industry’s future talent needs, we need to find innovative ways to reach new talent and offer them pathways to begin their careers in the industry,” said John Balchunas, NIIMBL Workforce Director. “The new projects will provide new tools to help us do that.”

The NIIMBL Global Health Fund (GHF) was established with funding contributed by the Gates Foundation to develop and implement innovative technologies to manufacture preventative medical countermeasures and biologics. Two projects funded as part of Project Call 8.1 focus on reducing the cost of goods to manufacture mRNA-based preventative medical countermeasures.

“With mRNA technologies opening the doors for new therapeutics, we are excited by the opportunities these projects provide to lower costs,” said Chris Roberts, NIIMBL Associate Institute Director.

The approximate value of these 11 projects includes NIIMBL funding plus cost share from participating organizations.

Since NIIMBL’s launch in 2017, the Institute has awarded 160 projects with a total investment of more than $134 million. NIIMBL is composed of 200+ member organizations from academia, industry, government, and non-profit organizations with a common goal to advance biopharmaceutical manufacturing. Funding for Project Call 8.1 projects is subject to project award negotiations.

For a description of each project and to learn more about NIIMBL, please visit the Project Call 8.1 page.

Project Call 8.1 List

Technology Projects

Project: Automation and Control of a Precipitation-based Continuous Downstream Process for High Titer Products
Lead: Rensselaer Polytechnic Institute
Participants: Astra Zeneca, Boehringer Ingelheim, Bristol Myers Squibb, ChromaTan, Dyadic, Janssen, Merck & Co., Inc., MilliporeSigma, PAK Bio, PendoTECH, Sanofi

Project: Rapid Bioburden and Sterility Testing for Biopharmaceutical Manufacturing
Lead: Mango, Inc.
Participant: Janssen

Project: Single Particle Analyzer for High-throughput and High-content Characterization of Nanoparticle-based RNA Therapy
Lead: Johns Hopkins University
Participants: CICS Analytics, Sartorius Stedim, National Institute of Standards and Technology (NIST)

Project: Integrating High-Throughput Chromatography and Data Science in a Platform for the Rapid and Accurate Quantification of Full, Partial, and Empty AAV Capsids
Lead: North Carolina State University
Participants: Bio Rad Laboratories, Bristol Myers Squibb, Cornell University, LigaTrap Technologies LLC, MilliporeSigma, Refeyn, Rensselaer Polytechnic Institute, Sartorius Stedim, University of Florida

Project: Obtaining Extensive At-line Input and Output Analytics Combined with Machine Learning to Improve Predictive CQA
Lead: Carnegie Mellon University
Participants: Johns Hopkins University, Merck & Co., Inc., Pfizer, Inc., University of Maryland Baltimore

Project: Spectro-acoustic Process Analytical Technology for Real-time Monitoring of Biopharmaceuticals
Lead: Purdue University
Participants: Merck & Co., Inc.

Workforce Projects

Project: Creation of National Standards for a Biomanufacturing Technician Registered Apprenticeship Program
Lead: Apprenti
Participants: InnovATEBIO, LifeScience Workforce Collaborative (LSWC)

Project: Life Sciences Career Hub: Biomanufacturing in Central Massachusetts
Lead: MassBio Education Foundation
Participants: Masschusetts Biomedical Initiative (MBI)

Project: A Day in the Life: Highlighting Careers in Biopharmaceutical Manufacturing
Lead: Bioscience Core Skills Institute (BCSI)
Participants: BioSTL, Merck & Co., Inc., Pfizer, Inc., Texas A&M Engineering Experiment Station (TEES)

Global Health Fund Projects

Project: Lowering the Cost of Goods for Making mRNA Utilizing Continuous Manufacturing
Lead: Sepragen
Participants: University of Massachusetts Lowell, University of Pennsylvania

Project: Lowering mRNA LNP Cost of Goods by Adding a Dose-sparing and Stabilizing Adjuvant
Lead: VaxForm

About NIIMBL

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness and security. NIIMBL is part of Manufacturing USA®, a network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.

Contact
News Media
Daniel Maiese
Communications Manager
302-831-3824
dmaiese@udel.edu

View original content to download multimedia:https://www.prnewswire.com/news-releases/niimbl-announces-11-new-technology-workforce-and-global-health-fund-projects-302441649.html

SOURCE National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Continue Reading

Technology

Netskope Recognized as Microsoft Security ISV of the Year at Microsoft Security Excellence Awards

Published

on

By

SANTA CLARA, Calif., April 29, 2025 /PRNewswire/ — Netskope, a leader in modern security and networking, today announced it has been recognized as Microsoft’s Security ISV of the Year in the Microsoft Security Excellence Awards 2025 presented by the Microsoft Intelligent Security Association (MISA). Netskope’s innovation and achievements over the past 12 months have elevated and distinguished the company within the Microsoft Intelligent Security Association (MISA), an ecosystem of independent software vendors (ISVs) and managed security service providers (MSSPs) that have integrated their security products and services with Microsoft Security technology.

At the Microsoft Security Excellence Awards on April 28, 2025, Microsoft celebrated Netskope among its winners in 9 award categories honoring partner trailblazers, solution innovators, customer and technology champions, and changemakers. This is the sixth year Microsoft is recognizing partners for their outstanding work in the security landscape.

“Receiving Microsoft’s Security ISV of the Year award is a testament to the value our partnership and strong technology integrations bring to our joint customers,” said Andy Horwitz, Senior Vice President of Global Partner Ecosystems, Netskope. “Our joint solutions across the Microsoft Security suite, including key integrations with Microsoft Purview, Microsoft Entra Suite, Microsoft Sentinel, Microsoft Copilot for Security, and more, provide enterprise customers with flexible, innovative, and differentiated security solutions for their most high-impact use cases.”

“I’m so pleased to congratulate Netskope, this year’s Microsoft Security Excellence awards recipient for Security ISV of the Year,” said Vasu Jakkal, Corporate Vice President, Microsoft Security Business. “Our incredible partner community embodies the spirit of Cyber Superheroes, working tirelessly to help customers face the ever-changing cybersecurity landscape. Each of this year’s award winners showcases extraordinary innovation and an unwavering commitment to the shared mission of security. Together, as a united team, we are proud to build a safer digital world for all.”

Established as an association to bring together Microsoft leaders, ISVs, and MSSPs, MISA focuses on collaborating to combat security threats and create a safer environment for all. Its mission is to provide intelligent, industry-leading security solutions that work together to help protect organizations at the speed and scale of AI in an ever-increasing threat landscape. Together with Microsoft stakeholders, MISA members voted on the Microsoft Security Excellence Awards, recognizing their peers’ efforts towards enhancing security.

For more:

Join Netskope at the Microsoft Booth #5744, Moscone North, for a deep dive into our integration with Purview DLP at the Microsoft Theater: Simplifying Data Security for the Modern Network with Microsoft Purview and Netskope One, Wednesday, April 30, 2025, 5:30-5:50pm PT.Register here for the Microsoft and Netskope Cocktail Hour at RSA 2025 on April 30, 4:00-6:00pm to connect with cybersecurity peers and learn how Netskope integrates with Microsoft Purview, Microsoft Entra Suite, and Microsoft Sentinel to strengthen your security posture.Visit Netskope at Booth #1135, Moscone South at RSA 2025.Learn more about Netskope’s offerings in the Microsoft Azure Marketplace.

About Netskope
Netskope, a leader in modern security and networking, addresses the needs of both security and networking teams by providing optimized access and real-time, context-based security for people, devices, and data anywhere they go. Thousands of customers, including more than 30 of the Fortune 100, trust the Netskope One platform, its Zero Trust Engine, and its powerful NewEdge network to reduce risk and gain full visibility and control over cloud, AI, SaaS, web, and private applications—providing security and accelerating performance without trade-offs.

Learn more at netskope.com, on LinkedIn, and Instagram.

Media Contacts:
press@netskope.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/netskope-recognized-as-microsoft-security-isv-of-the-year-at-microsoft-security-excellence-awards-302441628.html

SOURCE Netskope

Continue Reading

Technology

P3 Media Named Google Premier Partner for 2025, Recognized Among Top 3% of Agencies Worldwide

Published

on

By

NEW YORK, April 29, 2025 /PRNewswire/ — P3 Media, an award-winning ecommerce agency specializing in revenue acceleration for enterprise and omnichannel brands, has been named a Google Premier Partner for 2025, placing the agency in the top 3% of Google Partners globally.

This elite status recognizes P3 Media’s ability to drive sustained client growth across the Google Ads ecosystem through campaign excellence, strategic innovation, and certified expertise across all Google Ads products. As part of the Premier Partner evaluation, Google assessed factors including new and existing client growth, retention, product diversification, and overall annual ad spend.

P3’s Paid Media Acceleration program has powered over $2 billion in client revenue to date. New clients see an average ROAS improvement of 51% within the first six months, with Google Ads serving as a cornerstone of their cross-channel strategy.

“I like to say that excellence is table stakes,” said Ben Vandal, Director of Paid Media. “This distinction is a great benchmark of our media portfolio performance versus other agencies, but the true value we bring to our clients is how closely we work with them to achieve the best possible results.”

As a performance-driven Premier Partner, P3 Media focuses not just on launching effective campaigns, but on truly maximizing return on ad spend—often by combining advanced AI-driven tools with proprietary auditing techniques that monitor how big ad platforms actually use client money when “optimizing.”

“Any agency can turn on a PMax campaign and make a pretty good reporting dashboard,” said Aanarav Sareen, CEO and Cofounder of P3 Media. “What distinguishes our approach is that we examine the efficacy of every single dollar spent—even on AI-allocated campaigns—and then work hand-in-glove with our clients to build a strategy that can achieve maximum ROAS within their budget.”

For more about P3 Media’s performance marketing programs, visit pthreemedia.com.

Contact Information:

David Wagoner
P3 Media
425-681-0033
contact@pthreemedia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/p3-media-named-google-premier-partner-for-2025-recognized-among-top-3-of-agencies-worldwide-302441714.html

SOURCE P3 Media

Continue Reading

Trending